Search
for
Sort by
Research 151–180 of 354
- Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Dermatologic manifestations of thyroid disease: a literature review
- Endocrinology
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Pathomechanisms of immune-mediated alopecia
- Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans
- Extracellular Vesicles for Regenerative Medicine Applications
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- ANALYSIS OF CTLA 4 GENE +49A/G AND CT60 A/G POLYMORPHISMS IN ALOPECIA AREATA PATIENTS
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- The Influence of Flightless I: Regeneration versus Wound Healing
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions
- Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study
- 496 Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- The role of prostanoids in regulatory T cells and their implications in inflammatory diseases and cancers
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study